Womens Health Investment Outlook 2026

Contributors The insight report team would like to acknowledge: Stakeholders: Lovisa Afzelius, Flagship Pioneering; Roberta Annan, Annan Capital Partners; Hugo Arellano, RA Ventures; Elizabeth Bailey, Foreground Capital Partners; Freya Easton, SV Health Investors; Janet Foutty, Amboy Street Ventures; Emily Gaudiano, SV Health Investors; Julia Hoover, Ferring Pharmaceuticals; Anula Jayasuriya, Kidron Capital Assets; Ali Jazayeri, SV Health Investors; Sonia Kartha, RA Ventures; Jamie Kasuboski, Luma Group; Ramiz Khan, Wellcome Leap; Stasia Obremskey, Foreground Capital Partners; Cathrin Petty, CVC; Nina Rawal, Trill Impact Ventures; Natasha Rodgers, F-Prime Capital; Anastasiya Sybirna, F-Prime Capital; Sanskriti Thakur, Tower Capital; Matthew Worrall, Ferring Pharmaceuticals Additional contributors: Théo Baïssas, Boston Consulting Group; Vasundhara Bhatia, Boston Consulting Group; Emily Chung, Boston Consulting Group; Julie Dethier, Boston Consulting Group; Aidan Grasby, Boston Consulting Group; Haleh Nazeri, World Economic Forum; Jesus Santiago Borges, Boston Consulting Group; Lucy Svetec, Boston Consulting GroupProduction Bianca Gay-Fulconis Designer, 1-Pact Edition Tanya Korniichuk Illustrator, 1-Pact Edition Alison Moore Editor, Astra Content Simon Smith Editor, Astra ContentWorld Economic Forum Amira Ghouaibi Head, Global Alliance for Women’s Health Krista King Project Fellow, Closing the Funding Gap in Women’s Health Melissa Patel Lead, Women’s Health Responsible Investing, Global Alliance for Women’s HealthBoston Consulting Group Sarah Chamberlain Managing Director and Partner Alexandra Friedman Managing Director and Partner Supriya Jain Managing Director and Partner Trish Stroman Managing Director and Senior Partner Women’s Health Investment Outlook 41